WO2007047371A3 - Pharmaceutical packaging of an oral dosage combination - Google Patents

Pharmaceutical packaging of an oral dosage combination Download PDF

Info

Publication number
WO2007047371A3
WO2007047371A3 PCT/US2006/039894 US2006039894W WO2007047371A3 WO 2007047371 A3 WO2007047371 A3 WO 2007047371A3 US 2006039894 W US2006039894 W US 2006039894W WO 2007047371 A3 WO2007047371 A3 WO 2007047371A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral dosage
pharmaceutical packaging
package
dosage combination
active pharmaceutical
Prior art date
Application number
PCT/US2006/039894
Other languages
French (fr)
Other versions
WO2007047371A2 (en
Inventor
Andrew L Abrams
Anand V Gumaste
Raymundo A Sison
Original Assignee
Microdose Technologies Inc
Andrew L Abrams
Anand V Gumaste
Raymundo A Sison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Technologies Inc, Andrew L Abrams, Anand V Gumaste, Raymundo A Sison filed Critical Microdose Technologies Inc
Priority to AU2006304180A priority Critical patent/AU2006304180A1/en
Priority to CA002625776A priority patent/CA2625776A1/en
Priority to JP2008535670A priority patent/JP2009511191A/en
Priority to EP06825830A priority patent/EP1933815A2/en
Publication of WO2007047371A2 publication Critical patent/WO2007047371A2/en
Publication of WO2007047371A3 publication Critical patent/WO2007047371A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical delivery package comprising fixed unit dose quantities of two or more different active pharmaceutical ingredients (a) combined in a single delivery package, and (b) segregated from one another within said package wherein said package comprises a core containing a first active pharmaceutical ingredient surrounded at least in part by a capsule containing said second active pharmaceutical ingredient.
PCT/US2006/039894 2005-10-14 2006-10-13 Pharmaceutical packaging of an oral dosage combination WO2007047371A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2006304180A AU2006304180A1 (en) 2005-10-14 2006-10-13 Pharmaceutical packaging of an oral dosage combination
CA002625776A CA2625776A1 (en) 2005-10-14 2006-10-13 Pharmaceutical packaging of an oral dosage combination
JP2008535670A JP2009511191A (en) 2005-10-14 2006-10-13 Orally administered drug package method
EP06825830A EP1933815A2 (en) 2005-10-14 2006-10-13 Pharmaceutical packaging of an oral dosage combination

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72702905P 2005-10-14 2005-10-14
US60/727,029 2005-10-14

Publications (2)

Publication Number Publication Date
WO2007047371A2 WO2007047371A2 (en) 2007-04-26
WO2007047371A3 true WO2007047371A3 (en) 2007-12-06

Family

ID=37872260

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/039894 WO2007047371A2 (en) 2005-10-14 2006-10-13 Pharmaceutical packaging of an oral dosage combination

Country Status (6)

Country Link
EP (1) EP1933815A2 (en)
JP (1) JP2009511191A (en)
CN (1) CN101309675A (en)
AU (1) AU2006304180A1 (en)
CA (1) CA2625776A1 (en)
WO (1) WO2007047371A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101784263B (en) * 2007-06-08 2012-11-07 贝林格尔.英格海姆国际有限公司 Extended release formulation of nevirapine

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5667874B2 (en) * 2007-10-19 2015-02-12 ファイザー・プロダクツ・インク Multi-compartment container
EP2055292A1 (en) * 2007-10-30 2009-05-06 Pfizer Products Inc. Multi-compartmented container
EP2603900B1 (en) * 2010-08-13 2024-04-24 Intellimedicine, Inc. System and methods for the production of personalized drug products
ME01980B (en) 2010-11-19 2015-05-20 Gilead Sciences Inc Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate
EP3069708B1 (en) 2011-10-06 2018-05-09 Combocap, Inc. Capsule
JP2014079286A (en) * 2012-10-12 2014-05-08 Hiroaki Koga Container containing antimicrobial agent
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
EP2777802B1 (en) * 2013-12-03 2016-03-16 Capsugel Belgium NV Multi-compartment dosage form articles
CN104546899A (en) * 2015-02-01 2015-04-29 李宝齐 Oral solid pharmaceutical composition containing omeprazole
DK3534880T3 (en) * 2016-11-01 2022-07-25 Johnson & Johnson Consumer Inc LIQUID ORAL PHARMACEUTICAL DOSAGE FORM COMPRISING A HISTAMINE H2 RECEPTOR ANTAGONIST AND AN ACID NEUTRALIZING AGENT
IL283822B2 (en) * 2019-01-03 2024-05-01 Vibrant Ltd Device and method for delivering an ingestible medicament into the gastrointestinal tract of a user
WO2021176361A1 (en) 2020-03-02 2021-09-10 Craft Health Pte Ltd Method of manufacturing oral dosage forms for extended drug release

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0308637A1 (en) * 1987-08-21 1989-03-29 Dieter Dr. Stephan Capsules for the pharmaceutically active contents of a medicament
US5074426A (en) * 1986-11-13 1991-12-24 Warner-Lambert Company Dividable capsule
WO1999030693A2 (en) * 1997-12-17 1999-06-24 Axcan Pharma Inc. A double capsule for the administration of active principles in multiple therapies
WO2001052815A1 (en) * 2000-01-20 2001-07-26 Delsys Pharmaceutical Corporation Multi-step drug dosage forms
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
WO2002096347A2 (en) * 2001-05-31 2002-12-05 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US20040185100A1 (en) * 2003-03-03 2004-09-23 Sprl Franpharma Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
US20040224020A1 (en) * 2002-12-18 2004-11-11 Schoenhard Grant L. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20050053649A1 (en) * 2003-09-08 2005-03-10 Anne-Marie Chalmers Medication delivery device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603614B2 (en) * 1986-11-13 1990-11-22 Warner-Lambert Company Dividable capsule

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5074426A (en) * 1986-11-13 1991-12-24 Warner-Lambert Company Dividable capsule
EP0308637A1 (en) * 1987-08-21 1989-03-29 Dieter Dr. Stephan Capsules for the pharmaceutically active contents of a medicament
WO1999030693A2 (en) * 1997-12-17 1999-06-24 Axcan Pharma Inc. A double capsule for the administration of active principles in multiple therapies
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
WO2001052815A1 (en) * 2000-01-20 2001-07-26 Delsys Pharmaceutical Corporation Multi-step drug dosage forms
WO2002096347A2 (en) * 2001-05-31 2002-12-05 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US20040224020A1 (en) * 2002-12-18 2004-11-11 Schoenhard Grant L. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20040185100A1 (en) * 2003-03-03 2004-09-23 Sprl Franpharma Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
US20050053649A1 (en) * 2003-09-08 2005-03-10 Anne-Marie Chalmers Medication delivery device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUCKER H ET AL: "Feste orale und perorale Aerzneiformen", PHARMAZEUTISCHE TECHNOLOGIE, no. 2, 1991, pages 326, XP002146703 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101784263B (en) * 2007-06-08 2012-11-07 贝林格尔.英格海姆国际有限公司 Extended release formulation of nevirapine

Also Published As

Publication number Publication date
JP2009511191A (en) 2009-03-19
AU2006304180A1 (en) 2007-04-26
CA2625776A1 (en) 2007-04-26
EP1933815A2 (en) 2008-06-25
CN101309675A (en) 2008-11-19
WO2007047371A2 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
WO2007047371A3 (en) Pharmaceutical packaging of an oral dosage combination
WO2004009445A3 (en) Packaging and dispensing of rapid dissolve dosage form
WO2003035137A3 (en) Method and apparatus for dispensing inhalator medicament
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
WO2002096347A3 (en) Metering and packaging of controlled release medication
AU6909800A (en) Metering and packaging of controlled release medication
WO2007129127A8 (en) Dry powder inhalation device for the simultaneous administration of more than one medicament
WO2003039632A3 (en) A medicament container, a medicament dispensing kit for administering medication and a method for packaging the same
WO2006056711A3 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
WO2002060385A3 (en) Pharmaceutical formulation
AR057180A1 (en) PHARMACEUTICAL FORMULATION OF ORAL ABSORPTION INCLUDING INSULIN, BETWEEN OTHERS, AND THE METHOD OF ADMINISTRATION
WO2007109684A3 (en) Dose packaging system for load-dose titration administration of a liquid formulation
WO2005063203A3 (en) Multiparticulate formulations for oral delivery
ZA200700441B (en) Inhaler using pods
WO2010127205A3 (en) Fixed dose drug combination formulations
MY136136A (en) Pharmaceutical compositions containing terbinafin and use thereof
WO2005039481A3 (en) Oral drug delivery system
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
ATE401075T1 (en) MEDICINAL PRODUCT CONTAINING CYTISINE
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
WO2007120838A3 (en) Rapidly disintegrating solid oral dosage form of liquid dispersions
WO2003045305A3 (en) Acetaminophen compositions
WO2004062564A3 (en) Sedative non-benzodiazepine formulations

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680040313.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2008535670

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2625776

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/004895

Country of ref document: MX

Ref document number: 1850/CHENP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006825830

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006304180

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006304180

Country of ref document: AU

Date of ref document: 20061013

Kind code of ref document: A